At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.
The proposed diagnostic platform will be able to identify and determine resistance of bloodstream infections within three hours.
Two bacterial species together help feed the development of colon cancer, according to the New York Times.
A study led by Johns Hopkins describes a method for automating slow, inaccurate manual chart review when searching for signs of misdiagnosis.
The multi-analyte assay could screen for cancers that currently lack early-stage detection methods, including ovarian, liver, stomach, pancreatic, and esophageal cancers.
The promise of precision medicine isn't yet a reality for many cancer patients, NPR reports.
The team found that telomere fusions in pancreatic cells can act as potential predictive biomarkers for invasive cancer and high grade dysplasia in patients.
The company has been working for several years under NIH grants totaling more than $7 million and is now preparing for its first formal product launch.
The wide-ranging discussion with witnesses from Stanford, Johns Hopkins, and Editas Medicine touched on recent advances in research and questions of safety.
In Nature this week: new class of base editors, additional breast cancer risk loci, and more.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.